Advertisement

Optical coherence tomography angiography analysis of the choriocapillary layer in treatment-naïve diabetic eyes

  • Jingyuan Yang
  • Erqian Wang
  • Xinyu Zhao
  • Song Xia
  • Mingzhen Yuan
  • Huan Chen
  • Xiao Zhang
  • Youxin ChenEmail author
Retinal Disorders
  • 55 Downloads

Abstract

Purpose

To evaluate the capillary flow density (CFD) of choriocapillary (CC) microvasculature using optical coherence tomography angiography (OCT-A) in diabetic eyes and the association of CFD and systemic and metabolic factors.

Methods

Cross-sectional study. This study enrolled 282 eyes of 146 subjects, including 43 healthy control eyes, 56 diabetic eyes without diabetic retinopathy (DR), 43 eyes with mild nonproliferative DR (NPDR), 54 eyes with moderate NPDR, 38 eyes with severe NPDR, and 48 eyes with proliferative DR (PDR). CFD was measured in the CC layer. Clinical data were collected. Multiple linear regression analyses were performed to identify associated clinical variables.

Results

CFD in the CC layer presented a downward trend with DR progression. Comparisons of CFD in the CC layer between adjacent stages of DR revealed significant differences between severe NPDR and PDR using both 3-mm and 6-mm scan patterns (P = 0.003, P = 0.001). CFD in the CC layer in DR with diabetic macular edema (DME) was less than that in DR without DME using both 3-mm and 6-mm scan patterns (P < 0.001, P < 0.001). Coronary artery disease and atherosclerosis in other locations, estimated glomerular filtration rate, and increased HbA1c were associated with CFD in the CC layer using both 3-mm and 6-mm scan patterns (all P values < 0.05).

Conclusions

OCT-A revealed decreased CFD in the CC layer in the PDR stage and the presence of DME. Diabetic patients with apparently decreased CFD should be assessed carefully under general conditions.

Keywords

Diabetes Diabetic choroidopathy Diabetic retinopathy Optical coherence tomography Optical coherence tomography angiography Flow area Flow density 

Notes

Acknowledgments

Thanks are due to Chenxi Zhang, Minghang Pei, and Shan Wu for collecting data and supporting this study.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, Chen SJ, Dekker JM, Fletcher A, Grauslund J, Haffner S, Hamman RF, Ikram MK, Kayama T, Klein BE, Klein R, Krishnaiah S, Mayurasakorn K, O'Hare JP, Orchard TJ, Porta M, Rema M, Roy MS, Sharma T, Shaw J, Taylor H, Tielsch JM, Varma R, Wang JJ, Wang N, West S, Xu L, Yasuda M, Zhang X, Mitchell P, Wong TY (2012) Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35:556–564.  https://doi.org/10.2337/dc11-1909 CrossRefGoogle Scholar
  2. 2.
    Antonetti DA, Klein R, Gardner TW (2012) Diabetic retinopathy. N Engl J Med 366:1227–1239.  https://doi.org/10.1056/NEJMra1005073 CrossRefGoogle Scholar
  3. 3.
    Hayreh SS (2001) Blood flow in the optic nerve head and factors that may influence it. Prog Retin Eye Res 20:595–624CrossRefGoogle Scholar
  4. 4.
    McLeod DS, Lutty GA (1994) High-resolution histologic analysis of the human choroidal vasculature. Invest Ophthalmol Vis Sci 35:3799–3811Google Scholar
  5. 5.
    Lutty GA (2013) Effects of diabetes on the eye. Invest Ophthalmol Vis Sci 54:Orsf81–Orsf87.  https://doi.org/10.1167/iovs.13-12979 CrossRefGoogle Scholar
  6. 6.
    Takahashi A, Nagaoka T, Sato E, Yoshida A (2008) Effect of panretinal photocoagulation on choroidal circulation in the foveal region in patients with severe diabetic retinopathy. Br J Ophthalmol 92:1369–1373.  https://doi.org/10.1136/bjo.2007.136028 CrossRefGoogle Scholar
  7. 7.
    Agrawal R, Xin W, Keane PA, Chhablani J, Agarwal A (2016) Optical coherence tomography angiography: a non-invasive tool to image end-arterial system. Expert Rev Med Devices 13:519–521.  https://doi.org/10.1080/17434440.2016.1186540 CrossRefGoogle Scholar
  8. 8.
    Jia Y, Bailey ST, Wilson DJ, Tan O, Klein ML, Flaxel CJ, Potsaid B, Liu JJ, Lu CD, Kraus MF, Fujimoto JG, Huang D (2014) Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration. Ophthalmology 121:1435–1444.  https://doi.org/10.1016/j.ophtha.2014.01.034 CrossRefGoogle Scholar
  9. 9.
    Choi W, Waheed NK, Moult EM, Adhi M, Lee B, De Carlo T, Jayaraman V, Baumal CR, Duker JS, Fujimoto JG (2017) Ultrahigh speed swept source optical coherence tomography angiography of retinal and choriocapillaris alterations in diabetic patients with and without retinopathy. Retina (Philadelphia, Pa) 37:11–21.  https://doi.org/10.1097/iae.0000000000001250 CrossRefGoogle Scholar
  10. 10.
    Conti FF, Qin VL, Rodrigues EB, Sharma S, Rachitskaya AV, Ehlers JP, Singh RP (2018) Choriocapillaris and retinal vascular plexus density of diabetic eyes using split-spectrum amplitude decorrelation spectral-domain optical coherence tomography angiography. Br J Ophthalmol 103:452–456.  https://doi.org/10.1136/bjophthalmol-2018-311903
  11. 11.
    Nesper PL, Roberts PK, Onishi AC, Chai H, Liu L, Jampol LM, Fawzi AA (2017) Quantifying microvascular abnormalities with increasing severity of diabetic retinopathy using optical coherence tomography angiography. Invest Ophthalmol Vis Sci 58:Bio307–bio315.  https://doi.org/10.1167/iovs.17-21787 CrossRefGoogle Scholar
  12. 12.
    Carnevali A, Sacconi R, Corbelli E, Tomasso L, Querques L, Zerbini G, Scorcia V, Bandello F, Querques G (2017) Optical coherence tomography angiography analysis of retinal vascular plexuses and choriocapillaris in patients with type 1 diabetes without diabetic retinopathy. Acta Diabetol 54:695–702.  https://doi.org/10.1007/s00592-017-0996-8 CrossRefGoogle Scholar
  13. 13.
    Lim HB, Kim YW, Kim JM, Jo YJ, Kim JY (2018) The importance of signal strength in quantitative assessment of retinal vessel density using optical coherence tomography angiography. Sci Rep 8:12897.  https://doi.org/10.1038/s41598-018-31321-9 CrossRefGoogle Scholar
  14. 14.
    Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612CrossRefGoogle Scholar
  15. 15.
    Zhang M, Hwang TS, Campbell JP, Bailey ST, Wilson DJ, Huang D, Jia Y (2016) Projection-resolved optical coherence tomographic angiography. Biomed Opt Express 7:816–828.  https://doi.org/10.1364/boe.7.000816 CrossRefGoogle Scholar
  16. 16.
    Fukushima I, McLeod DS, Lutty GA (1997) Intrachoroidal microvascular abnormality: a previously unrecognized form of choroidal neovascularization. Am J Ophthalmol 124:473–487CrossRefGoogle Scholar
  17. 17.
    Funatsu H, Yamashita H, Ikeda T, Nakanishi Y, Kitano S, Hori S (2002) Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with diabetic macular edema and other retinal disorders. Am J Ophthalmol 133:537–543CrossRefGoogle Scholar
  18. 18.
    Melancia D, Vicente A, Cunha JP, Abegao Pinto L, Ferreira J (2016) Diabetic choroidopathy: a review of the current literature. Graefes Arch Clin Exp Ophthalmol 254:1453–1461.  https://doi.org/10.1007/s00417-016-3360-8 CrossRefGoogle Scholar
  19. 19.
    Paine SK, Mondal LK, Borah PK, Bhattacharya CK, Mahanta J (2017) Pro- and antiangiogenic VEGF and its receptor status for the severity of diabetic retinopathy. Mol Vis 23:356–363Google Scholar
  20. 20.
    Ting DSW, Tan GSW, Agrawal R, Yanagi Y, Sie NM, Wong CW, San Yeo IY, Lee SY, Cheung CMG, Wong TY (2017) Optical coherence tomographic angiography in type 2 diabetes and diabetic retinopathy. JAMA Ophthalmol 135:306–312.  https://doi.org/10.1001/jamaophthalmol.2016.5877 CrossRefGoogle Scholar
  21. 21.
    Lee DH, Yi HC, Bae SH, Cho JH, Choi SW, Kim H (2018) Risk factors for retinal microvascular impairment in type 2 diabetic patients without diabetic retinopathy. PLoS One 13:e0202103.  https://doi.org/10.1371/journal.pone.0202103 CrossRefGoogle Scholar
  22. 22.
    Van Belle E, Rivard A, Chen D, Silver M, Bunting S, Ferrara N, Symes JF, Bauters C, Isner JM (1997) Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines. Circulation 96:2667–2674CrossRefGoogle Scholar
  23. 23.
    Pedersen BK (2017) Anti-inflammatory effects of exercise: role in diabetes and cardiovascular disease. Eur J Clin Investig 47:600–611.  https://doi.org/10.1111/eci.12781 CrossRefGoogle Scholar
  24. 24.
    Ohno T, Takamoto S, Motomura N (2008) Diabetic retinopathy and coronary artery disease from the cardiac surgeon’s perspective. Ann Thorac Surg 85:681–689.  https://doi.org/10.1016/j.athoracsur.2007.07.066 CrossRefGoogle Scholar
  25. 25.
    Pant S, Deshmukh A, Gurumurthy GS, Pothineni NV, Watts TE, Romeo F, Mehta JL (2014) Inflammation and atherosclerosis--revisited. J Cardiovasc Pharmacol Ther 19:170–178.  https://doi.org/10.1177/1074248413504994 CrossRefGoogle Scholar
  26. 26.
    Hsieh YT, Tsai MJ, Tu ST, Hsieh MC (2018) Association of abnormal renal profiles and proliferative diabetic retinopathy and diabetic macular edema in an Asian population with type 2 diabetes. JAMA Ophthalmol 136:68–74.  https://doi.org/10.1001/jamaophthalmol.2017.5202 CrossRefGoogle Scholar
  27. 27.
    Chang YC, Wu WC (2013) Dyslipidemia and diabetic retinopathy. Rev Diabet Stud 10:121–132.  https://doi.org/10.1900/rds.2013.10.121 CrossRefGoogle Scholar
  28. 28.
    Sas KM, Kayampilly P, Byun J, Nair V, Hinder LM, Hur J, Zhang H, Lin C, Qi NR, Michailidis G, Groop PH, Nelson RG, Darshi M, Sharma K, Schelling JR, Sedor JR, Pop-Busui R, Weinberg JM, Soleimanpour SA, Abcouwer SF, Gardner TW, Burant CF, Feldman EL, Kretzler M, Brosius FC 3rd, Pennathur S (2016) Tissue-specific metabolic reprogramming drives nutrient flux in diabetic complications. JCI Insight 1:e86976.  https://doi.org/10.1172/jci.insight.86976 CrossRefGoogle Scholar
  29. 29.
    Suzuma I, Hata Y, Clermont A, Pokras F, Rook SL, Suzuma K, Feener EP, Aiello LP (2001) Cyclic stretch and hypertension induce retinal expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2: potential mechanisms for exacerbation of diabetic retinopathy by hypertension. Diabetes 50:444–454CrossRefGoogle Scholar
  30. 30.
    Sizmaz S, Kucukerdonmez C, Pinarci EY, Karalezli A, Canan H, Yilmaz G (2013) The effect of smoking on choroidal thickness measured by optical coherence tomography. Br J Ophthalmol 97:601–604.  https://doi.org/10.1136/bjophthalmol-2012-302393 CrossRefGoogle Scholar
  31. 31.
    Teberik K (2019) The effect of smoking on macular, choroidal, and retina nerve fiber layer thickness. Turk J Ophthalmol 49:20–24.  https://doi.org/10.4274/tjo.galenos.2018.80588 CrossRefGoogle Scholar
  32. 32.
    Remen T, Pintos J, Abrahamowicz M, Siemiatycki J (2018) Risk of lung cancer in relation to various metrics of smoking history: a case-control study in Montreal. BMC Cancer 18:1275.  https://doi.org/10.1186/s12885-018-5144-5 CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Ophthalmology, Peking Union Medical College HospitalPeking Union Medical College, Chinese Academy of Medical SciencesBeijingChina

Personalised recommendations